CABA Cabaletta Bio Inc

$CABA Again, I am writing to share you Cabaletta Bio strong safety profile in context of the deaths from Novartis The Novartis deaths were attributed to rapid cell growth that was triggered an inflammtory response, the reason being is their rapid manufacturing of the cells were hyper-aggressive upon entering the body leading to a massive over-activation of the immune system. Novartis manufacturing of cells were 2 days, while $CABA is at 9 days allowing time for the cells to be somewhat weaker, when they infuse into the body they do so at a more steady pace compared to 2 days, since these ones would be more potent upon hitting the bloodstream. You are trading off time here correct, but safety should be at the forefront. The death from BMS was from septic pneumonia, I believe here PC-free data could be gamechanger as it lowers the risk by dropping chemo in preserving the patients existing immune system to fight off the infection Happy holdings, our time will come.

$CABA black rock increase the ownership and today caba presents in a big european conference! Big day!

$CABA Bullish news. Investment giant BlackRock has just filed an SEC Form 13 F announcing that it has increased its stake in $CABA over 35% and as of Sept 30 owned 7.7% of all common stock. Specifically, BlackRock’s reported stake jumped 35.4% in Q3. Its October 27 filing shows 13,013,495 shares, or 7.7%, as of September 30, versus 9,613,912 shares, or 5.9%, at June 30. That’s 3,399,583 more shares, comparing its consecutive 13G filings. A substantial increase in institutional exposure and an encouraging development for CABA bulls. Let’s go!!! New 13G/A, filed October 27: https://www.sec.gov/Archives/edgar/data/1759138/000201238326003765/xslSCHEDULE_13G_X02/primary_doc.xml Previous 13G, filed July 27: https://www.sec.gov/Archives/edgar/data/1759138/000201238326002220/xslSCHEDULE_13G_X02/primary_doc.xml

$CABA this is what iam talking about. short sellers are buing back. this thing happen every single f day

$CABA The pattern is textbook bullish. It shook out to $1.42, buyers defended that level, and then it ripped to close at the highs. Options backed it up too, with heavy call buying all day. See you at $4 soon.

$CABA $KYTX data continues to derisk the safety concerns seen with other Non human products. Kytx and Caba should see a big lift with this continuing positive data in my opinion. They do not share the same issues as the stopped programs.

$CABA Bain, Lily and co invested $150,000,000 at $2.90 only 23 weeks ago. ALL executive Insiders bought substantially at market at $2.26 odd beginning of this year. Only good news and more cash in the bank from fully advertised warrant sales = approx $350,000,000 in the bank. $LLY chief science officer advising the board. Potential cure for multiple autoimmune diseases and possibly preconditioning free. Multi billion potential. Trading below cash in the bank value. Zero enterprise or technology value? Mark this post…👍

$CABA I wish we can sign a petition to limit the shorts action especially in small/ micro cap . It should not be allowed in specific sizes.

$CABA perfect timing right before the fed decision tomorrow NO RATE HIKE Looks good for the rest of the week

$CABA interesting price action. I’ve just been sitting and chilling with my 151,400 shares. My average of $2.57 is considerably above where we are now, but I haven’t been worried given that it’s fallen below where I am based on no news at all. If there were news about adverse safety events totally different story, but there hasn’t been. To Me this fall past $2.50 - the strike price of the warrant has been nothing but market manipulation and a bad macro due or high interest rates to shake out weak hands that have not done their due diligence as many of us holding big positions have. I will sit here and wait and chill in my position waiting for the major catalysts that will occur in the second half of next year and into 2028.

$CABA added my last available 20k at the possible triple bottom 1.54. I was going to wait until tomorrow but it's done. Much appreciate tbe adjusted DCA! Now let's go Green tomorrow

$CABA now announce a presentation for November and at that time reveal more solid Preconditioning free efficacy data. Back to $4. My personal prediction.

$CABA As of September 30, 2026, BlackRock owned about 13 million Cabaletta shares, 7.7% of the company. That's nearly four times its stake from late 2024, which shows steady institutional support heading into the 2027 data. LFG!!!!🚀🚀

$CABA Bought $XERS at $1.20 years ago. Point is, patience pays. If they keep pumping good results, then it’s a matter of time. LOAD UP at these low prices IF you believe in the company.

$CABA I cannot begin to imagine two stocks with more Explosive potential than Cabaletta Bio and $ALT Altimmune... $SPY

$CABA This is absolutely insane. Company is trading almost under cash value. Those criminals on WS should really go to prison. Those thieves are robbing, and destroying not only share holders but also sience.

$CABA I think you need a lot of courage to hold a stock like this, and I believe a lot of investors are afraid, hence us trading near cash. You got capital concerns, since CAR-T therapies are expensive, and trial assoicated deaths. Any deaths that happen in any Cabaletta program will destroy this stock, and I believe Novartis and BMS showed that by pausing their programs. $CABA only lead asset are CAR-T therapies, but if it continues to showcase a strong safety profile, we will be fine in the long-run, I have shared before my reasons why Rese-cell is different, and I am content on holding, the more we get closer to RESET-Myositis results, and BLA submission next year, the concerns of death become less and less Dilution is still a concern, I just hope they raise after the result, I have seen companies do that and the stock continues to rise after, as there is a lot of competition for big funds to get involved

$CABA I am not worried about this one. As we can see whole stock market is going down recently. Patience is the key to success.

$CABA a lot of pharmaceutical companies are down 50-60% aint only cabaletta. Now its not time to sell.. if you are losing 30-60% and you are selling because of the panic attack i dont know what to say probably you are not for this kind of market and stocks. . This price is for buying and the big funds are knowing that. If they decide to buy then the price will explode. If you have patient until the mid of november the price will be a lot different then. .

Why is $CABA about to run? There’s a huge divergence on 20 and 200 EMAs. RSI super low. Technicals are such that algos are picking this up and the run starts this week, even today. That yellow and blue line are absolutely too far away from eachother and they just can’t stretch any further. Warrants were priced at $2.50 so this is also very undervalued now. Amazing product too. Lots of reasons to reverse NOW! $PDSB $IBRX